Sunday, 2 October, 2022
TopicOxford vaccine

Topic: Oxford vaccine

Delaying 2nd AstraZeneca vaccine shot by upto 45 weeks improves immune response: Oxford study

A preprint of the study by researchers of Oxford University noted that a third dose of the AstraZeneca vaccine will also lead to a substantial increase in immune response.

Covid-19 pandemic: Brussels seeks EU unity over AstraZeneca, push for J&J vaccine in Hong Kong

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Study of Oxford-AstraZeneca vaccinations in children paused after blood clots emerge in adults

UK’s drug regulator is investigating rare cases of blood clots in adults who were given Oxford-AstraZeneca shot. No safety issues have arisen in children’s trial, Oxford says.

Drug regulator DCGI extends shelf life of Covishield vaccine from 6 to 9 months

In a letter to the Serum Institute, Drugs Controller General of India Somani said the institute is permitted to apply the shelf life of 9 months to unlabeled vials available on hand.

Govt tracking AstraZeneca vaccine ‘blood clot’ issue, but no ‘signal of concern’ yet

NITI Aayog’s Member (Health) Dr V.K. Paul says vaccinations with the Serum Institute of India-made Covishield will continue ‘with full vigour’.

Oxford-AstraZeneca vaccine safe and works extremely well, says UK PM Boris Johnson

Amid reports that doses were causing blood clot-related complications, Johnson said that six months since its discovery, multiple countries like India are producing the vaccine.

3-month gap between doses of Oxford vaccine more effective against Covid, Lancet study finds

According to Oxford University researchers, the first dose of the vaccine offers 76% protection, making it safe for the interval between doses to be extended to 3 months.

Serum Institute, UNICEF sign pact for supply of 1.1 billion doses of AstraZeneca, Novavax

UNICEF will have access to these vaccines for around 100 countries, for approximately USD 3 a dose for the low- and lower middle-income countries.

Covaxin a ‘buffet’ vaccine that can deal with mutations, others ‘a la carte’ — top virologist

India’s vaccination strategy is smartly-designed and will strengthen healthcare workers to handle a second wave, says Dr V. Ravi, former basic sciences dean at NIMHANS.

Malaysia healthcare at ‘breaking point’, UK pharmacies set to offer vaccine & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe. 

On Camera


Wild elephants monitored under thermal UAVs in Maharashtra | RESQ Charitable Trust

We monitored wild elephants, leopards in villages with thermal drones first time in Maharashtra

Whether it's monitoring wildlife, mitigating conflict, capturing of wildlife on field, UAVs are effective tools to complement existing on-ground efforts.
A man counts Indian currency notes inside a shop in Mumbai, India | Reuters/Francis Mascarenhas

RBI tells state refiners to reduce dollar buying in spot market, contain sharp fall in rupee

RBI has ensured that $9 billion has been made available at overseas branches of some Indian banks for the country's three state-run refiners to tap, according to sources.


File photo of former Air Chief Marshal RKS Bhadauria after flying a MiG-21 of 51 Squadron at the Srinagar airbase | ANI

Famed IAF pilot Abhinandan Varthaman’s MiG-21 Squadron bows out from Srinagar today

Known as the ‘Sword Arms’, number-plating of the squadron was done Friday. It has made way for MiG-29s to be the new 'guardian of the Valley'.

India’s hijab supporters will lose even if they win SC battle. Because the real war is political

In a highly polarised time, cornered minorities tend to lean back and protect the roots and fundamentals of what is so dear to them. Politically, it can often be a bad trap.